Supplement to the Guidelines for the Management of Transient Ischemic Attacks A Statement From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association

In 1994, a panel of the American Heart Association Stroke Council published guidelines for the management of transient ischemic attacks (TIAs).1 Over the last 5 years, many significant advances in medical and surgical therapy for patients with TIAs have occurred. In addition, new data regarding risk factors for cerebral ischemic events have become available. These scientific advances have prompted this supplement to the 1994 guidelines, which provides updated recommendations for management of patients with TIAs. Specific stroke-prevention strategies after a TIA are tailored to the most likely cause of the event and the patient’s underlying risk factors as determined by a focused, expedient diagnostic evaluation. For more information about epidemiology, etiology, and diagnostic evaluation of TIAs, see the original guidelines.1 For the current report, panel members followed the rules of evidence used by the 1998 American College of Chest Physicians Conference on Antithrombotic Therapy.2 The approach to stroke prevention among patients who have already had their first TIA includes identification and modification of stroke risk factors. Nonmodifiable risk markers for stroke include age, sex, race-ethnicity, and heredity.3 Although these risk markers cannot be changed, they nonetheless serve as important identifiers of patients at risk of stroke, for whom an aggressive search for other modifiable risk factors might be particularly important. Modifiable stroke risk factors include hypertension, cardiac disease (particularly atrial fibrillation), diabetes, hypercholesterolemia, cigarette smoking, excessive use of alcohol, and physical inactivity. Numerous prospective studies and clinical trials have consistently shown a decreased risk of stroke with control of most of these conditions, although few of these studies were conducted in TIA cohorts.1 Reduction of both systolic and diastolic pressure in hypertensive subjects substantially reduces stroke risk.4 5 Reduction of isolated systolic hypertension to <140 mm Hg in the elderly, for example, in the …

[1]  R. Andersen,et al.  OBESITY AND ITS RELATIONSHIP TO MARITAL STATUS IN US ADULTS. RESULTS FROM THE THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1994 , 2001 .

[2]  J. Hirsh,et al.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. , 2001, Chest.

[3]  Inger,et al.  AN ANALYSIS OF THE LOWEST EFFECTIVE INTENSITY OF PROPHYLACTIC ANTICOAGULATION FOR PATIENTS WITH NONRHEUMATIC ATRIAL FIBRILLATION , 2000 .

[4]  F. Buonanno,et al.  Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. , 1999, The New England journal of medicine.

[5]  R Brian Haynes,et al.  Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial , 1999, The Lancet.

[6]  A. Norbash,et al.  Outcome of angioplasty for atherosclerotic intracranial stenosis. , 1999, Stroke.

[7]  J. Manson,et al.  Exercise and risk of stroke in male physicians. , 1996, Stroke.

[8]  R. Sacco,et al.  A new clinical prediction instrument for TIA and ischemic stroke , 1999 .

[9]  R. Sacco,et al.  The protective effect of moderate alcohol consumption on ischemic stroke. , 1999, JAMA.

[10]  V. Babikian,et al.  Risk factor modification in stroke prevention: the experience of a stroke clinic. , 1999, Stroke.

[11]  W J Powers,et al.  Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. , 1999, JAMA.

[12]  S. Kittner,et al.  Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. , 1998, Stroke.

[13]  T. Truelsen,et al.  Intake of beer, wine, and spirits and risk of stroke : the copenhagen city heart study. , 1998, Stroke.

[14]  D. Sackett,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.

[15]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[16]  Diener Hc.  Aspirin dose in secondary prevention of stroke. , 1998 .

[17]  William J. Powers,et al.  Importance of Hemodynamic Factors in the Prognosis of Symptomatic Carotid Occlusion , 1998 .

[18]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[19]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[20]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[21]  R. Sacco,et al.  Homocysteine as a Risk Factor for Ischemic Stroke: An Epidemiological Story in Evolution , 1998, Neuroepidemiology.

[22]  J. Grotta,et al.  Clinical features of moyamoya disease in the United States. , 1998, Stroke.

[23]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[24]  S. Davis,et al.  Surgery for prevention of stroke , 1998, The Lancet.

[25]  J. Slattery,et al.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) , 1998, The Lancet.

[26]  M Henry,et al.  Current global status of carotid artery stent placement. , 1998, Catheterization and cardiovascular diagnosis.

[27]  P. Yarnold,et al.  Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases , 1998, Annals of Internal Medicine.

[28]  R. Hobson,et al.  Status of carotid angioplasty and stenting trials. , 1998, Journal of vascular surgery.

[29]  Beverley Balkau,et al.  High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study , 1998, Diabetes Care.

[30]  T. Shima,et al.  Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. , 1998, Stroke.

[31]  R. Sacco,et al.  Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. , 1998, Stroke.

[32]  G. Guyatt,et al.  Grades of recommendation for antithrombotic agents. , 1998, Chest.

[33]  H. Diener.  Aspirin dose in secondary prevention of stroke. , 1998, Cerebrovascular diseases.

[34]  F. Verheugt,et al.  A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin , 1997, Annals of neurology.

[35]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[36]  C. Hennekens,et al.  Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. , 1997, JAMA.

[37]  Cathy M. Helgason,et al.  American Heart Association Prevention Conference IV: Prevention and Rehabilitation of Stroke Introduction , 1997 .

[38]  P. Bell,et al.  Carotid and Vertebral Artery Transluminal Angioplasty Study , 1997, The Lancet.

[39]  P. Wolf,et al.  Risk factors : Prevention and Rehabilitation of Stroke , 1997 .

[40]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[41]  P. Gorelick.  Stroke prevention: windows of opportunity and failed expectations? A discussion of modifiable cardiovascular risk factors and a prevention proposal. , 1997, Neuroepidemiology.

[42]  E. O’Brien,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.

[43]  C. Forbes,et al.  EUROPEAN STROKE PREVENTION STUDY 2: DIPYRIDAMOLE AND ACETYLSALICYLIC ACID IN THE SECONDARY PREVENTION OF STROKE , 1997, International journal of clinical practice.

[44]  P. Wolf,et al.  American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. , 1997, Stroke.

[45]  R. Weinshilboum,et al.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[46]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[47]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[48]  S. Kemp,et al.  Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. , 1996, Archives of internal medicine.

[49]  J. Toole,et al.  EC-IC bypass 10 years later: is it valuable? , 1996, Surgical neurology.

[50]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[51]  W. J. Hamilton,et al.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[52]  D. Singer,et al.  An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.

[53]  R. Hart,et al.  Aspirin wars: the optimal dose of aspirin prevent stroke. , 1996, Stroke.

[54]  C. Patrono,et al.  Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen? , 1996, Stroke.

[55]  M. Kaste,et al.  Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts. , 1996, Stroke.

[56]  P. Gaines,et al.  European Carotid Angioplasty Trial , 1996 .

[57]  P. Gaines,et al.  European carotid angioplasty trial. , 1996, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[58]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[59]  D B Matchar,et al.  US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices. , 1995, Stroke.

[60]  M. B. Brown,et al.  The Warfarin-Aspirin Symptomatic Intracranial Disease Study , 1995, Neurology.

[61]  G. Nesbit,et al.  Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. , 1995, Stroke.

[62]  C. Furberg,et al.  Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) , 1995, The American journal of cardiology.

[63]  Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. , 1995, The American journal of cardiology.

[64]  J. Slattery,et al.  Equivalence of Measurements of Carotid Stenosis: A Comparison of Three Methods on 1001 Angiograms , 1994, Stroke.

[65]  C. Furberg,et al.  Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.

[66]  D. Newell,et al.  Dynamic Transcranial Doppler Assessment of Positional Vertebrobasilar Ischemia , 1994, Stroke.

[67]  G. Leinsinger,et al.  Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. , 1994, Journal of neurosurgery.

[68]  J. Whisnant,et al.  A population-based study of stroke in the setting of mitral valve prolapse: risk factors and infarct subtype classification. , 1994, Mayo Clinic proceedings.

[69]  L. Wilkins.  Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. , 1994 .

[70]  R. Kronmal,et al.  Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. , 1994, Circulation.

[71]  J. Rothrock,et al.  Ticlopidine hydrochloride use and threatened stroke. , 1994, The Western journal of medicine.

[72]  R. Spetzler,et al.  Endarterectomy of the intradural vertebral artery via the far lateral approach. , 1993, Neurosurgery.

[73]  H Yonas,et al.  Increased stroke risk predicted by compromised cerebral blood flow reactivity. , 1993, Journal of neurosurgery.

[74]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[75]  B. Norrving,et al.  Low-dose aspirin and stroke. , 1993, Stroke.

[76]  R. Higashida,et al.  Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. , 1993, Journal of neurosurgery.

[77]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[78]  V. Fuster,et al.  Low-dose aspirin and stroke. "It ain't necessarily so". , 1992, Stroke.

[79]  M. Pessin,et al.  Embolism from vertebral artery origin occlusive disease , 1992, Neurology.

[80]  G. Sicard.  MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or mild (0–29%) carotid stenosis: European Carotid Surgery Trialist' Collaborative Group. Lancet 1991;337:1235-43 , 1992 .

[81]  B. Widder,et al.  Course of Carotid Artery Occlusions With Impaired Cerebrovascular Reactivity , 1992, Stroke.

[82]  J. Grotta,et al.  Prevention of stroke with ticlopidine , 1992, Neurology.

[83]  L. Caplan.  Vertebrobasilar occlusive disease , 1992 .

[84]  D. Lindhout,et al.  Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. , 1992, Neurology.

[85]  Ralph G. Dacey,et al.  Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis , 1991 .

[86]  H. Winn,et al.  Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. , 1991, JAMA.

[87]  P. W. Mccormick,et al.  Disabling cerebral transient ischemic attacks. , 1991, Journal of neurosurgery.

[88]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[89]  A. Algra,et al.  A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. , 1991, The New England journal of medicine.

[90]  R. Berguer,et al.  Vertebrobasilar Arterial Disease , 1991 .

[91]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[92]  L. Bonavina,et al.  Surgical management of extracranial vertebral artery occlusive disease. , 1991, The Journal of cardiovascular surgery.

[93]  C. Warlow,et al.  MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis , 1991, The Lancet.

[94]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[95]  T. Jensen,et al.  MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group , 1991 .

[96]  M. Dyken,et al.  Stroke Risk Factors , 1991 .

[97]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[98]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[99]  M. Dujovny,et al.  Intracranial vertebral endarterectomy. , 1990, Neurosurgery.

[100]  R. A. Solomon,et al.  Cerebral Revascularization: A Review , 1989, Neurosurgery.

[101]  H. Adams,et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.

[102]  V. Hachinski,et al.  THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE , 1989, The Lancet.

[103]  S. Chuang,et al.  The surgical treatment of childhood moyamoya disease. , 1987, Journal of neurosurgery.

[104]  M. Hadley,et al.  Vertebrobasilar insufficiency. Part 2. Microsurgical treatment of intracranial vertebrobasilar disease. , 1987, Journal of neurosurgery.

[105]  M. Hadley,et al.  Vertebrobasilar insufficiency Part 1" Microsurgical treatment of extracranial vertebrobasilar disease , 1987 .

[106]  A. Lowenthal.  THE EUROPEAN STROKE PREVENTION STUDY (ESPS) Principal End-points , 1985, The Lancet.

[107]  W. Baker,et al.  Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: The EC/IC Bypass Study Group. N Engl J Med 1985;313:1191–1200 , 1986 .

[108]  I. Awad,et al.  Extracranial-intracranial bypass surgery: a critical analysis in light of the International Cooperative Study. , 1986, Neurosurgery.

[109]  L. Wilkins.  Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group. , 1985 .

[110]  Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. , 1985, The New England journal of medicine.

[111]  J. Ausman,et al.  Surgical reconstruction of the proximal vertebral artery. , 1984, Journal of neurosurgery.

[112]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.

[113]  P. Touboul,et al.  "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. , 1983, Stroke.

[114]  A. L. Carney.  Vertebral artery surgery: historical development, basic concepts of brain hemodynamics, and clinical experience of 102 cases. , 1981, Advances in neurology.

[115]  H. Kikuchi,et al.  Treatment of moyamoya disease with STA-MCA anastomosis. , 1978, Journal of neurosurgery.

[116]  A randomized trial of aspirin and sulfinpyrazone in threatened stroke. , 1978, The New England journal of medicine.

[117]  Hilary Putnam,et al.  It Ain't Necessarily So , 1962 .